BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,195.00
+10.00 (0.31%)
Last updated: Dec 5, 2025, 10:19 AM KST
4.41%
Market Cap 26.09B
Revenue (ttm) 18.65B
Net Income (ttm) -246.68M
Shares Out 8.18M
EPS (ttm) -30.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,071
Average Volume 13,144
Open 3,185.00
Previous Close 3,185.00
Day's Range 3,185.00 - 3,215.00
52-Week Range 2,750.00 - 4,390.00
Beta 1.22
RSI 34.43
Earnings Date Nov 14, 2025

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 83
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.